Golden Matrix (GMGI) Ready for Super Bowl LIX with 900+ AI-Powered Lines & Prop Bets
- 131
Las Vegas, Valetta--(Newsfile Corp. - February 9, 2025) - The Super Bowl LVIII is just hours away. Meridianbet, part of Golden Matrix Group (NASDAQ: GMGI), is setting new industry standards, rolling out a record-breaking 880+ unique betting options for the biggest sporting event in the U.S. Meridianbet, part of the GMGI, is also bringing innovation to Super Bowl LVIII with its AI Sports Betting Recommender, an advanced feature that personalizes betting experiences by analyzing player behavior, past wagers, and real-time trends to suggest the most relevant betting options. This AI-driven approach enhances user engagement, making it easier for bettors to discover tailored opportunities with maximum potential.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Golden Matrix (GMGI) sets a new Super Bowl betting record with over 900 AI-powered odds, delivering the most extensive wagering options in the industry.
- Meridianbet's Sports Betting Recommender, personalizes player experience by analyzing behavioral patterns for tailored betting suggestion
- Super Bowl LIX bets include Scorigami, MVP position, shirt number totals, and the revolutionary Empty Bet feature, allowing users to create custom wagers.
Click image above to view full announcement.
Contact:
Milan Koricanac
[email protected]
Head of Global PR
Source: Meridianbet Group
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240193
Newsfile Corp. is a press release service for companies of all sizes. With a distribution of over 6,000 media and financial databases, Newsfile delivers press releases to a global audience.
- Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting
- Hikvision releases 2024 full-year and 2025 first-quarter financial results
- Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
- Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
- ROSEN, A LEADING LAW FIRM, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ZYXI
- ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages NAPCO Security Technologies, Inc. Investors to Inquire About Securities Class Action Investigation - NSSC
